Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VILDAGLIPTIN vs VIMSELTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VILDAGLIPTIN vs VIMSELTINIB: Safety Overview

Metric VILDAGLIPTIN VIMSELTINIB
Total FAERS Reports 2,063 170
Deaths Reported 181 0
Death Rate 8.8% N/A
Hospitalizations 1,064 5
Average Patient Age 70.8 yrs 45.6 yrs
% Female Patients 49.6% 55.4%
FDA Approval Date N/A Feb 14, 2025
Manufacturer N/A Deciphera Pharmaceuticals, LLC
Route N/A ORAL
Marketing Status N/A Prescription